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Introduction: Verruciform xanthoma is a rare, benign lesion characterized by hyperkeratosis and aggregates of
foam cell macrophages. Here, we describe a case of verruciform xanthoma on the scrotum, in which the
immunohistochemical localization of monocyte chemoattractant protein-1, a chemokine of the C-C or beta family
that has been shown to induce the recruitment of monocytes for injured tissue, was analyzed to determine which
cells release chemoattractants for macrophages.
Case presentation: A 75-year-old Japanese man with a well-defined nodule on the left scrotum was admitted to
the hospital. An excision biopsy revealed epidermal papillary proliferation with parakeratosis, hyperkeratosis, and
infiltration of foam cell macrophages, whereby a pathological diagnosis of benign cutaneous verruciform xanthoma
was made. Immunohistochemically, monocyte chemoattractant protein-1 was observed predominantly on
cytokeratin AE1/AE3-positive differentiating keratinocytes in the prickle cell layer. However, while infiltrating
macrophages were densely stained for monocyte chemoattractant protein-1, keratinocytes in the basal and
parabasal layers were almost negative.
Conclusions: We demonstrated that keratinocyte-derived monocyte chemoattractant protein-1 plays an important
role in the establishment of particular histological features of verruciform xanthoma. However, in the present case,
unlike in previous reports, monocyte chemoattractant protein-1 immunostaining in keratinocytes in the basal and
parabasal layers was not prominent. We speculate that in the active phase of verruciform xanthoma, when
continuous stimuli that release monocyte chemoattractant protein-1 from keratinocytes to the surrounding stromal
area are present, the apparent immunostaining of monocyte chemoattractant protein-1 can be underestimated
because of the void created by accelerated keratinocyte release from the cytoplasmic fraction.Introduction
Verruciform xanthoma (VX) is an uncommon, benign
lesion first reported in the oral cavity in 1971 [1]. A sur-
vey of 282 cases of VX involving different mucocuta-
neous sites has established the lesion as a distinct
clinicopathologic entity [2]. It occurs mainly in oral mu-
cosa and occasionally at extra-oral sites, including those
on the penis [3], the scrotum [4], and the vulva [5]. Clin-
ically, the lesion is painless, asymptomatic, slow growing
(up to 2cm in size), and slightly elevated with a* Correspondence: kitazawa@m.ehime-u.ac.jp
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reproduction in any medium, provided the oryellowish, reddish, or grayish rough and granular surface
[6], mimicking conventional papilloma, verrucous car-
cinoma and squamous cell carcinoma [7]. Histologically,
VX is characterized by papillomatosis, parakeratosis, and
accumulation of foam cell macrophages [1,8,9].
This study describes a case of VX on the scrotum and
analyzes the immunohistochemical localization of the
major macrophage chemotactic factor, monocyte chemo-
attractant protein-1 (MCP-1), to elucidate the particular
tumor-macrophage interaction in VX.
Case presentation
A 75-year-old Japanese man was admitted to our hos-
pital with a gradually growing cutaneous polypoid massThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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proximately one year before. The tumor measured
13mm in diameter with relatively well-defined whitish-
yellow outlines (Figure 1a). Histological examination of
an excisional biopsy revealed epidermal papillary prolif-
eration with parakeratosis, hyperkeratosis, and neutro-
phil infiltration (Figures 1b and 2a). Although mitotic
figures were noted in the basal layer (Figure 2a, arrows),
cellular atypia was not prominent. Besides abundant
plasma cells in the upper dermis, numerous foamy
macrophages infiltrated the dermal papillae, forming a
characteristic clear zone beneath the basement membrane
(Figure 2a, asterisks). Histopathologically, the tumor was
diagnosed as a benign cutaneous verruciform xanthoma
with negative lateral and deep surgical margins.
To determine which cells release chemoattractants for
macrophages, formalin-fixed and paraffin-embedded sec-
tions were stained for cytokeratin (AE1/AE3, M3515;
Dako, Carpinteria, CA, USA; 1:200), CD68 (M0876;
Dako; 1:100) and MCP-1 (DA103; BD Biosciences, San(a)
(b)
Figure 1 (a) Pedunculated, rubbery soft, red nodule (13mm in
diameter) with a mulberry-like surface on the scrotum. (b) The
lesion consists of pseudocarcinomatous acanthotic epidermis and
stroma with dilated vessels under low magnification (hematoxylin
and eosin stain). High magnification of the boxed area in Figure 2(a).Diego, CA, USA; 1:40, 1:200, 1:800). After microwave
heat-induced epitope retrieval, endogenous peroxidase ac-
tivity was blocked with hydrogen peroxide (H2O2) in
methanol. Indirect immunohistochemistry with the use of
horseradish peroxidase conjugated anti-mouse rabbit anti-
body revealed that cytokeratin AE1/AE3 was strongly
positive in differentiating epidermal keratinocytes, and
weakly positive in keratinocytes in the basal and parabasal
layers (Figure 2b). However, strong CD68 staining was
observed almost exclusively in foamy cells infiltrating be-
neath the basal cells (Figure 2c). The parts densely stained
for MCP-1 were observed in the differentiating cytokera-
tin AE1/AE3-positive keratinocytes. Clusters of the infil-
trating macrophages also stained positive for MCP-1
(Figure 2d).
Discussion
Previous studies revealed a possible pathogenesis of VX
that included the local release of lipid by damaged kerati-
nocytes through inflammation [10]. Under the assumption
that MCP-1 produced by the proliferating keratinocytes,
especially by those with close contact with foamy macro-
phages, plays some roles in developing this particular
histological feature, we investigated the immunohisto-
chemical localization of MCP-1. In the present case, how-
ever, MCP-1 expression was observed in keratinocytes in
the papilloma lesion, but its localization was observed pre-
dominantly in differentiating keratinocytes in the prickle
cell layer.
MCP-1, produced by many types of cells, is a chemo-
kine of the C-C or beta family that has been shown to
induce the recruitment of monocytes for injured tissue;
its excessive production by keratinocytes has been impli-
cated in psoriasis and other inflammatory skin diseases;
transgenic mice that express murine MCP-1 in the basal
layer of epidermis do not, however, exhibit spontaneous
cutaneous inflammation or any other discernible skin
pathology, but show hypersensitivity responses to eli-
cited inflammation in the skin by the recruitment of
dendritic and Langerhans cells [11]. One of the apparent
pathophysiological roles of MCP-1 in the skin is, there-
fore, chemotaxis of immunomodulators to the skin, and
the overexpression of MCP-1 per se may be a requisite
but not sufficient condition for causing VX.
A previous immunohistochemical study on a series of
VX cases has revealed that MCP-1 localizes in the basal
layer of the epidermis [12]. To explain an aspect of such
immunohistochemical differences, we formulated two
hypotheses: firstly, scarring beneath the basal layer pre-
vented basal cells from releasing MCP-1, as reported for
keloid-derived fibroblasts [13], and secondly, accelerated
release of MCP-1 exhausted significant amounts of
MCP-1 from the cytoplasm of keratinocytes in the basal




Figure 2 Immunohistochemical evaluation of chemoattractants for macrophages. (a) Hematoxylin and eosin staining shows verruciform
xanthoma consisting of hyperkeratosis, a few mitotic figures (arrows) and infiltrating foamy cells (asterisks, ×200). (b) Cytokeratin AE1/AE3
showing positive immunostaining in the epithelial cells of the verruciform xanthoma (×200). (c) CD68 showing positive cytoplasmic
immunostaining exclusively in the majority of foam cells infiltrating beneath the basal cells (×200). (d) The parts densely stained for monocyte
chemoattractant protein-1 (MCP-1) are observed in the differentiating keratinocytes over the basal and parabasal layers. Clusters of the infiltrating
macrophages are also stained positive, albeit less intensely, for MCP-1 (arrows, ×200).
Ito et al. Journal of Medical Case Reports 2012, 6:260 Page 3 of 4
http://www.jmedicalcasereports.com/content/6/1/260shows a reparative phenotype when overlying a scar or the
sclerotic dermis of lichen sclerosus [13,14]. This stromal-
keratinocyte interaction is believed to account for the
change of keratin AE1 expression from from basal kerati-
nocytes in normal skin to spinous keratinocytes in scars
and lichen sclerosus. Thus, our finding of MCP-1 expres-
sion in spinous keratinocytes, rather than the basal layer,
may be the consequence of an altered dermal/stromal
phenotype. It is likely not coincidence that both lichen
sclerosus and verruciform xanthoma also show dermal
lymphedema; the latter is thought to be the consequence
of the former [15]. Additionally, when continuous stimuli
to release MCP-1 from keratinocytes to the surrounding
stromal area is present, apparent immunostaining of
MCP-1 can be underestimated. Also, MCP-1 immunohis-
tochemically localizes in infiltrating or aggregating macro-
phages themselves [16]. Thus, macrophages recruited by
MCP-1 may sustain themselves in both paracrine and
autocrine ways.Conclusions
Although other factors associated with MCP-1 that
characterize particular histopathological features of VX
have not yet been established, we speculate that MCP-1expression in proliferating and differentiating keratino-
cytes may have a supplemental role in the establishment
of VX.
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